Scientists have developed a 3D printed tissue that closely
mimics the human liver's sophisticated structure and function, which
could be used for patient-specific drug testing and disease modelling.
Researchers said the advance could help pharmaceutical companies save
time and money when developing new drugs. "We've made a tool that
pharmaceutical companies could use to do pilot studies on their new
drugs, and they won't have to wait until animal or human trials to test a
drug's safety and efficacy on patients," said Shaochen Chen, professor
at the University of California, San Diego.
Existing liver models for drug screening so far lack the complex micro-architecture and diverse cell makeup. The researchers engineered a human liver tissue model that more closely resembles the real thing - a diverse combination of liver cells and supporting cells systematically organised in a hexagonal pattern. "We've engineered a functioning liver tissue that matches what you'd see under a microscope," said Chen. "The liver is unique in that it receives a dual blood supply with different pressures and chemical constituents," said Shu Chien, professor at UC San Diego.
"Our model has the potential of reproducing this intricate blood supply system, providing unprecedented understanding of the complex coupling between circulation and metabolic functions of the liver in health and disease," said Chien. The researchers used a novel bioprinting technology, which can rapidly produce complex 3D microstructures that mimic the sophisticated features found in biological tissues. The liver tissue was printed in two steps. First, the team printed a honeycomb pattern of 900-micrometre-sized hexagons, each containing liver cells derived from human induced pluripotent stem cells.
An advantage of human induced pluripotent stem cells is they are patient-specific, which makes them ideal materials for building patient-specific drug screening platforms. Since these cells are derived from a patient's skin cells, researchers do not need to extract any cells from the liver to build liver tissue. Then, endothelial and mesenchymal supporting cells were printed in the spaces between the hexagons. The entire structure a 3X3 millimetre square, 200 micrometres thick - takes just seconds to print. This is a vast improvement over other methods to print liver models, which typically take hours.
The structure was cultured in vitro for at least 20 days. The researchers then tested the resulting tissue's ability to perform various liver functions, such as albumin secretion and urea production, and compared it to other models. They found that their model was able to maintain these functions over a longer time period than other liver models.
Their model also expressed a relatively higher level of a key enzyme that is considered to be involved in metabolising many of the drugs administered to patients. The study was published in the journal PNAS.
Existing liver models for drug screening so far lack the complex micro-architecture and diverse cell makeup. The researchers engineered a human liver tissue model that more closely resembles the real thing - a diverse combination of liver cells and supporting cells systematically organised in a hexagonal pattern. "We've engineered a functioning liver tissue that matches what you'd see under a microscope," said Chen. "The liver is unique in that it receives a dual blood supply with different pressures and chemical constituents," said Shu Chien, professor at UC San Diego.
"Our model has the potential of reproducing this intricate blood supply system, providing unprecedented understanding of the complex coupling between circulation and metabolic functions of the liver in health and disease," said Chien. The researchers used a novel bioprinting technology, which can rapidly produce complex 3D microstructures that mimic the sophisticated features found in biological tissues. The liver tissue was printed in two steps. First, the team printed a honeycomb pattern of 900-micrometre-sized hexagons, each containing liver cells derived from human induced pluripotent stem cells.
An advantage of human induced pluripotent stem cells is they are patient-specific, which makes them ideal materials for building patient-specific drug screening platforms. Since these cells are derived from a patient's skin cells, researchers do not need to extract any cells from the liver to build liver tissue. Then, endothelial and mesenchymal supporting cells were printed in the spaces between the hexagons. The entire structure a 3X3 millimetre square, 200 micrometres thick - takes just seconds to print. This is a vast improvement over other methods to print liver models, which typically take hours.
The structure was cultured in vitro for at least 20 days. The researchers then tested the resulting tissue's ability to perform various liver functions, such as albumin secretion and urea production, and compared it to other models. They found that their model was able to maintain these functions over a longer time period than other liver models.
Their model also expressed a relatively higher level of a key enzyme that is considered to be involved in metabolising many of the drugs administered to patients. The study was published in the journal PNAS.
No comments:
Post a Comment